SELLAS Life Sciences Group Inc (NASDAQ: SLS) kicked off on Friday, up 5.16% from the previous trading day, before settling in for the closing price of $1.55. Over the past 52 weeks, SLS has traded in a range of $0.77-$2.27.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 45.94%. While this was happening, its average annual earnings per share was recorded 41.33%. With a float of $103.08 million, this company’s outstanding shares have now reached $105.30 million.
Let’s determine the extent of company efficiency that accounts for 15 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
SELLAS Life Sciences Group Inc (SLS) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of SELLAS Life Sciences Group Inc is 2.11%, while institutional ownership is 25.57%. The most recent insider transaction that took place on Jun 12 ’25, was worth 14,800. In this transaction Director of this company bought 10,000 shares at a rate of $1.48, taking the stock ownership to the 20,400 shares. Before that another transaction happened on May 30 ’25, when Company’s Director bought 20,000 for $1.69, making the entire transaction worth $33,800. This insider now owns 30,400 shares in total.
SELLAS Life Sciences Group Inc (SLS) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.1 earnings per share (EPS), higher than consensus estimate (set at -0.13) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 41.33% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.93% during the next five years compared to 45.94% growth over the previous five years of trading.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Trading Performance Indicators
Take a look at SELLAS Life Sciences Group Inc’s (SLS) current performance indicators. Last quarter, stock had a quick ratio of 4.91.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.33, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.37 in one year’s time.
Technical Analysis of SELLAS Life Sciences Group Inc (SLS)
Looking closely at SELLAS Life Sciences Group Inc (NASDAQ: SLS), its last 5-days average volume was 1.59 million, which is a drop from its year-to-date volume of 2.56 million. As of the previous 9 days, the stock’s Stochastic %D was 41.68%.
During the past 100 days, SELLAS Life Sciences Group Inc’s (SLS) raw stochastic average was set at 51.55%, which indicates a significant increase from 43.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1016 in the past 14 days, which was lower than the 0.1267 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.7615, while its 200-day Moving Average is $1.3775. However, in the short run, SELLAS Life Sciences Group Inc’s stock first resistance to watch stands at $1.6700. Second resistance stands at $1.7100. The third major resistance level sits at $1.7800. If the price goes on to break the first support level at $1.5600, it is likely to go to the next support level at $1.4900. Now, if the price goes above the second support level, the third support stands at $1.4500.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Key Stats
The company with the Market Capitalisation of 171.63 million has total of 105,297K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -30,880 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -5,810 K.
